Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 15:10:goab046.
doi: 10.1093/gastro/goab046. eCollection 2022.

Microbiome therapeutics: exploring the present scenario and challenges

Monika Yadav  1 , Nar Singh Chauhan  1
Affiliations
Review

Microbiome therapeutics: exploring the present scenario and challenges

Monika Yadav et al. Gastroenterol Rep (Oxf). .

Abstract

Human gut-microbiome explorations have enriched our understanding of microbial colonization, maturation, and dysbiosis in health-and-disease subsets. The enormous metabolic potential of gut microbes and their role in the maintenance of human health is emerging, with new avenues to use them as therapeutic agents to overcome human disorders. Microbiome therapeutics are aimed at engineering the gut microbiome using additive, subtractive, or modulatory therapy with an application of native or engineered microbes, antibiotics, bacteriophages, and bacteriocins. This approach could overcome the limitation of conventional therapeutics by providing personalized, harmonized, reliable, and sustainable treatment. Its huge economic potential has been shown in the global therapeutics market. Despite the therapeutic and economical potential, microbiome therapeutics is still in the developing stage and is facing various technical and administrative issues that require research attention. This review aims to address the current knowledge and landscape of microbiome therapeutics, provides an overview of existing health-and-disease applications, and discusses the potential future directions of microbiome modulations.

Keywords: engineered microbiome; fecal microbiome transplantation; human microbiome; microbiome therapeutics; prebiotics; probiotics.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Role of microbiome augmentation in the maintenance of healthy life
Figure 2.
Figure 2.
Overview of the strategies used as microbiome therapeutics
Figure 3.
Figure 3.
The differential functions of fecal microbiota transplantation and probiotics in treating human disorders
Figure 4.
Figure 4.
Challenges associated with the field of microbiome therapeutics
See this image and copyright information in PMC

References

    1. Walter J, Ley R.. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 2011;65:411–29. - PubMed
    1. DeGruttola AK, Low D, Mizoguchi A. et al. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 2016;22:1137–50. - PMC - PubMed
    1. Kashyap PC, Chia N, Nelson H. et al. Microbiome at the frontier of personalized medicine. Mayo Clin Proc 2017;92:1855–64. - PMC - PubMed
    1. Mimee M, Citorik RJ, Lu TK.. Microbiome therapeutics—advances and challenges. Adv Drug Deliv Rev 2016;105:44–54. - PMC - PubMed
    1. Sheth RU, Cabral V, Chen SP. et al. Manipulating bacterial communities by in situ microbiome engineering. Trends Genet TIG 2016;32:89–200. - PMC - PubMed

LinkOut - more resources